Viral safety of B-domain deleted recombinant factor VIII

被引：23

作者：

Charlebois, TS

O'Connell, BD

Adamson, SR

Brink-Nilsson, H

Jernberg, M

Eriksson, B

Kelley, BD

机构：

[1] Genet Inst Inc, Cambridge, MA 02140 USA

[2] Pharmacia AB, Stockholm, Sweden

来源：

SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 02期

关键词：

D O I：

10.1053/shem.2001.25891

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：32 / 39

页数：8

共 33 条

[1] DESIGN AND OPERATION OF A RECOMBINANT MAMMALIAN-CELL MANUFACTURING PROCESS FOR RFVIII [J].

ADAMSON, R .

ANNALS OF HEMATOLOGY, 1994, 68 :S9-S14

[2]

Adamson S, 1998, SEMIN HEMATOL, V35, P22

[3] ENDOGENOUS ORIGIN OF DEFECTIVE RETROVIRUS-LIKE PARTICLES FROM A RECOMBINANT CHINESE-HAMSTER OVARY CELL-LINE [J].

ANDERSON, KP ;

LOW, MAL ;

LIE, YS ;

KELLER, GA ;

DINOWITZ, M .

VIROLOGY, 1991, 181 (01) :305-311

[4]

[Anonymous], 1996, MMWR, V45, P29

[5]

[Anonymous], 1997, INT C HARM TECHN REQ

[6] VIRUS SAFETY CONSIDERATIONS FOR RECOMBINANT FACTOR-VIII (RFVIII, KOGENATE) [J].

ARNOLD, D .

HAEMOPHILIA, 1995, 1 :22-23

[7] HUMAN PARVOVIRUS-B19 INFECTION IN HEMOPHILIACS 1ST INFUSED WITH 2 HIGH-PURITY, VIRALLY ATTENUATED FACTOR-VIII CONCENTRATES [J].

AZZI, A ;

CIAPPI, S ;

ZAKVRZEWSKA, K ;

MORFINI, M ;

MARIANI, G ;

MANNUCCI, PM .

AMERICAN JOURNAL OF HEMATOLOGY, 1992, 39 (03) :228-230

[8] HUMAN PARVOVIRUS INFECTION IN HEMOPHILIACS 1ST INFUSED WITH TREATED CLOTTING FACTOR CONCENTRATES [J].

CORSI, OB ;

AZZI, A ;

MORFINI, M ;

FANCI, R ;

ROSSIFERRINI, P .

JOURNAL OF MEDICAL VIROLOGY, 1988, 25 (02) :165-170

[9] TT virus is present in a high frequency of Italian hemophilic patients transfused with plasma-derived clotting factor concentrates [J].

Chen, BP ;

Rumi, MG ;

Colombo, M ;

Lin, YH ;

Ramaswamy, L ;

Luna, J ;

Liu, JK ;

Prati, D ;

Mannucci, M .

BLOOD, 1999, 94 (12) :4333-4336

[10]

EisHubinger AM, 1996, THROMB HAEMOSTASIS, V76, P1120

← 1 2 3 4 →